Peptide cyclization is a powerful strategy for enhancing conformational constraint, improving receptor binding, and increasing metabolic stability. Several cyclization strategies are available, each with distinct advantages and applications.
Head-to-tail cyclization connects the N-terminus to the C-terminus, creating a macrocyclic peptide. This strategy provides maximum conformational constraint and is often used to create highly potent and selective receptor agonists and antagonists. Head-to-tail cyclization requires that the peptide termini be in close proximity in the bioactive conformation, which is not always the case.
Side-chain cyclization connects two side chains within the peptide, creating a constrained loop. Common side-chain cyclization strategies include lactam bridges (connecting lysine and glutamic acid side chains) and disulfide bridges (connecting cysteine residues). Side-chain cyclization allows for more flexible placement of constraints and can be used to stabilize specific conformations.
Disulfide bridges are the most common form of peptide cyclization in nature, stabilizing the structures of many bioactive peptides. Disulfide bridges form through oxidation of two cysteine residues, creating a covalent link that constrains the peptide conformation. While disulfide bridges are effective at stabilizing peptides, they can be reduced in vivo, limiting their utility for therapeutic applications.
At PeptideHub, we offer all major cyclization strategies, with expert guidance on selecting the optimal approach for your specific peptide and application. Our experienced team can design and synthesize cyclic peptides with high purity and yield, providing the constrained peptides needed for your research or development program.